Shanghai Pharmaceuticals Holding Co., Ltd manufactures pharmaceuticals. The Company develops and sells chemical and Chinese traditional medicines, healthcare products, and other products. Shanghai Pharmaceuticals Holding markets its products throughout China.

Shanghai Pharmaceuticals Holding (601607 CH)

Announcement on Approval for Clinical Trial of I048

Announcement on Approval for Clinical Trial of Sodium Tetradecyl Sulphate Injection

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Shanghai Pharmaceuticals Holding (601607 CH)

Announcement on Approval for Clinical Trial of I048

Announcement on Approval for Clinical Trial of Sodium Tetradecyl Sulphate Injection

Announcement on SRD4610 Obtaining Approval of FDA on Orphan-drug Designation

Announcement on the Acceptance of Application for Marketing Authorization of Rinaraxil Glutarate Capsules (X842 Project)

Announcement on Approval for Production of Apremilast Tablets

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)